40 results
424B2
PYXS
Pyxis Oncology Inc
3 Apr 24
Prospectus for primary offering
8:45pm
strategy and plans and objectives of management for future operations, are “forward-looking statements” for the purposes of this prospectus … manufacturing, commercialization and marketing capabilities and strategy;
our plans to expand our pipeline of product candidates and further develop
8-K
EX-99.2
9s3yu hu7qa4
21 Mar 24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
7:44am
8-K
EX-99.1
nnzrv
23 Aug 23
Pyxis Oncology Successfully Completes Acquisition of Apexigen
8:47am
424B3
zjq op2k9ryca48ina
30 Jun 23
Prospectus supplement
4:05pm
S-4/A
c80wqi61nile7
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
2e12691 1co
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
mbcujc9xf0gni2zed
25 May 23
Business combination disclosure
8:14am
425
EX-99.1
v9s6wg
24 May 23
Business combination disclosure
4:55pm
8-K
EX-99.1
ixqwnz2 16yi1ef
24 May 23
Regulation FD Disclosure
4:53pm
S-3
kbi3 e9vz53rk1bgx
1 Nov 22
Shelf registration
4:51pm